Significance of L-Carnitine for Human Health

被引:164
作者
Adeva-Andany, Maria M. [1 ]
Calvo-Castro, Isabel [1 ]
Fernandez-Fernandez, Carlos [1 ]
Donapetry-Garcia, Cristobal [1 ]
Maria Pedre-Pineiro, Ana [1 ]
机构
[1] Hosp Juan Cardona, Rua Pardo Bazan, Ferrol, Spain
关键词
acetyl-coA; organic cation transporter-2; carnitine acetyltransferase; carnitine octanoyltransferase; carnitine palmitoyltransfer; HUMAN SKELETAL-MUSCLE; ACYLCARNITINE TRANSLOCASE DEFICIENCY; ACID BETA-OXIDATION; FATTY-ACID; TRANSPORTER OCTN2; PALMITOYLTRANSFERASE; WEIGHT-LOSS; PLASMA ACYLCARNITINES; ACTIVE-TRANSPORT; GLUCOSE DISPOSAL;
D O I
10.1002/iub.1646
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carnitine acyltransferases catalyze the reversible transfer of acyl groups from acyl-coenzyme A esters to L-carnitine, forming acyl-carnitine esters that may be transported across cell membranes. L-Carnitine is a water-soluble compound that humans may obtain both by food ingestion and endogenous synthesis from trimethyl-lysine. Most L-carnitine is intracellular, being present predominantly in liver, skeletal muscle, heart and kidney. The organic cation transporter-2 facilitates L-carnitine uptake inside cells. Congenital dysfunction of this transporter causes primary L-carnitine deficiency. Carnitine acetyltransferase is involved in the export of excess acetyl groups from the mitochondria and in acetylation reactions that regulate gene transcription and enzyme activity. Carnitine octanoyltransferase is a peroxysomal enzyme required for the complete oxidation of very long-chain fatty acids and phytanic acid, a branched-chain fatty acid. Carnitine palmitoyltransferase-1 is a transmembrane protein located on the outer mitochondrial membrane where it catalyzes the conversion of acyl-coenzyme A esters to acyl-carnitine esters. Carnitine acyl-carnitine translocase transports acyl-carnitine esters across the inner mitochondrial membrane in exchange for free L-carnitine that exits the mitochondrial matrix. Carnitine palmitoyltransferase-2 is anchored on the matrix side of the inner mitochondrial membrane, where it converts acyl-carnitine esters back to acyl-coenzyme A esters, which may be used in metabolic pathways, such as mitochondrial beta-oxidation. L-Carnitine enhances nonoxidative glucose disposal under euglycemic hyperinsulinemic conditions in both healthy individuals and patients with type 2 diabetes, suggesting that L-carnitine strengthens insulin effect on glycogen storage. The plasma level of acyl-carnitine esters, primarily acetylcarnitine, increases during diabetic ketoacidosis, fasting, and physical activity, particularly high-intensity exercise. Plasma concentration of free L-carnitine decreases simultaneously under these conditions. (C) 2017 IUBMB Life
引用
收藏
页码:578 / 594
页数:17
相关论文
共 112 条
[1]   Plasma Acylcarnitine Profiles Suggest Incomplete Long-Chain Fatty Acid β-Oxidation and Altered Tricarboxylic Acid Cycle Activity in Type 2 Diabetic African-American Women [J].
Adams, Sean H. ;
Hoppel, Charles L. ;
Lok, Kerry H. ;
Zhao, Ling ;
Wong, Scott W. ;
Minkler, Paul E. ;
Hwang, Daniel H. ;
Newman, John W. ;
Garvey, W. Timothy .
JOURNAL OF NUTRITION, 2009, 139 (06) :1073-1081
[2]  
ANGELINI A, 1993, DRUG EXP CLIN RES, V19, P219
[3]   Disposition and metabolite kinetics of oral L-carnitine in humans [J].
Bain, Marcus A. ;
Milne, Robert W. ;
Evans, Allan M. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (10) :1163-1170
[4]   Human skeletal muscle carnitine palmitoyltransferase I activity determined in isolated intact mitochondria [J].
Berthon, PM ;
Howlett, RA ;
Heigenhauser, GJF ;
Spriet, LL .
JOURNAL OF APPLIED PHYSIOLOGY, 1998, 85 (01) :148-153
[5]   PURIFICATION AND PROPERTIES OF CARNITINE ACETYLTRANSFERASE FROM HUMAN LIVER [J].
BLOISI, W ;
COLOMBO, I ;
GARAVAGLIA, B ;
GIARDINI, R ;
FINOCCHIARO, G ;
DIDONATO, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 189 (03) :539-546
[6]   Effect of oral acetyl L-carnitine arginate on resting and postprandial blood biomarkers in pre-diabetics [J].
Bloomer, Richard J. ;
Fisher-Wellman, Kelsey H. ;
Tucker, Patrick S. .
NUTRITION & METABOLISM, 2009, 6
[7]   Long-Term Follow-Up of Bezafibrate Treatment in Patients With the Myopathic Form of Carnitine Palmitoyltransferase 2 Deficiency [J].
Bonnefont, J. P. ;
Bastin, J. ;
Laforet, P. ;
Aubey, F. ;
Mogenet, A. ;
Romano, S. ;
Ricquier, D. ;
Gobin-Limballe, S. ;
Vassault, A. ;
Behin, A. ;
Eymard, B. ;
Bresson, J. L. ;
Djouadi, F. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (01) :101-108
[8]   Noninvasive Assessment of Exercise-Related Intramyocellular Acetylcarnitine in Euglycemia and Hyperglycemia in Patients With Type 1 Diabetes Using 1H Magnetic Resonance Spectroscopy A randomized single-blind crossover study [J].
Boss, Andreas ;
Kreis, Roland ;
Jenni, Stefan ;
Ith, Michael ;
Nuoffer, Jean-Marc ;
Christ, Emanuel ;
Boesch, Chris ;
Stettler, Christoph .
DIABETES CARE, 2011, 34 (01) :220-222
[9]   PHARMACOKINETIC CONSIDERATIONS FOR THE THERAPEUTIC USE OF CARNITINE IN HEMODIALYSIS-PATIENTS [J].
BRASS, EP .
CLINICAL THERAPEUTICS, 1995, 17 (02) :176-185
[10]  
Celik F., 2017, J OBSTET GYNAECOL, V37, P1